SASKATOON, Saskatchewan--(BUSINESS WIRE)--#agriculture--The Global Agri-Food Advancement Partnership (GAAP) and Ag-West Bio are welcoming five food innovation companies from South Africa, Argentina, the Netherlands, and Mexico to take part in the Navigate
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances fe
$107 million in cash on the balance sheet at close Reduces applicable margin for borrowings by fifty basis points Aligns ongoing capital structure actions to support acquisition strategy HOUSTON--(BUSINESS WIRE)--DXP Enterprises, Inc. (NASDAQ: DXPE) t
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) (“Alpha Cognition” or the “Company”) announces that it has completed a second closing pursuant to its previously announced private placement of units of t
Trusted CDMO partner for small molecule API development and tailored polymers for drug delivery announces refreshed visual brand and website, highlighting industry-leading custom solutions for APIs and biomedical materialsTORONTO--(BUSINESS WIRE)--GL CHE
-- Aim is to study a universal CAR T cell therapy, targeting CD45 and including CD45 epitope-edited hematopoietic stem cells, with the potential to treat blood and bone marrow cancers --CAMBRIDGE, Mass. & BASEL, Switzerland--(BUSINESS WIRE)--Cimeio Thera
KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative high-value biologics and cell and gene therapy products Experienced team of biopharma ser
EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (“Aurinia” or the “Company”), a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, today announced that da
LAVAL, Québec & WEST PALM BEACH, Fla.--(BUSINESS WIRE)--BIOQuébec and BioFlorida, preeminent life sciences associations from Québec and Florida, are proud to announce the signing of a Memorandum of Understanding (MOU). This agreement is set to intensif
Lunresertib + camonsertib combination demonstrated clear signals of anti-tumor activity across multiple tumor types and all selected genotypes Overall response of 33.3% across all tumor types and 50% RECIST response in patients with heavily pre-treated g
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.